Journal profile · Rehabilitation
Supportive Care in Cancer
ISSN 0941-4355 · eISSN 1433-7339 · Springer Berlin Heidelberg · UNITED STATES · Bimonthly · Founded 1993
Supportive Care in Cancer: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.4; hybrid open access; APC about USD 4,690; median 176 days to acceptance (195 articles, last 24 months); community-reported acceptance: about 50%; 1,163 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Supportive Care in Cancer is published by Springer Berlin Heidelberg and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer survivorship and care, Palliative Care and End-of-Life Issues and Childhood Cancer Survivors' Quality of Life, together about 40.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Supportive Care in Cancer (SCC) provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. It covers the physical, psychosocial and spiritual aspects of the cancer patient’s journey from diagnosis through to end-of-life care, with a focus on interventions to mitigate symptoms and side effects during this journey. Supportive Care in Cancer is committed to publishing high quality original research, reviews and clinical guidance that contribute to the advancement of supportive care. We do not normally accept papers reporting on unmet needs, pilot/feasibility studies, or instrument development studies. Case studies are no longer accepted for consideration by SCC.
From the journal's Aims & Scope
Research area (LetPub): Rehabilitation
Editor-in-chief Fredrick D AshburyPublisher website
Editorial board by country: none in mainland China; most named United States 21, Canada 7, United Kingdom 3, Germany 3, Netherlands 3 (56 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer survivorship and careMedicine26.2%
- Palliative Care and End-of-Life IssuesMedicine7.7%
- Childhood Cancer Survivors' Quality of LifeMedicine6.5%
- Oral health in cancer treatmentMedicine5.9%
- Cancer-related cognitive impairment studiesMedicine5.5%
- Nutrition and Health in AgingMedicine4.2%
- Nausea and vomiting managementMedicine3.8%
- Pain Management and Opioid UseMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Rehabilitation | Zone 2 |
| Minor | Health Care Sciences & Services | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
| Minor | Health Care Sciences & Services | Zone 3 |
| Minor | Rehabilitation | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Rehabilitation | Zone 2 |
| Minor | Health Care Sciences & Services | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.4LetPub ·
- Impact factor (publisher) 2025
- 3.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.7Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- SJR 2026-06
- 1.03LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 98LetPub ·
- h-index
- 174OpenAlex ·
- i10-index
- 6,910OpenAlex ·
- 2-year mean citedness
- 1.97OpenAlex ·
- Self-citation rate
- 8.8%LetPub ·
- Share of gold OA articles
- 35.89%LetPub ·
Volume
- Articles per year
- 1,057LetPub ·
- Downloads per year (publisher) 2025
- 4,300,000Publisher website ·
Articles by year OpenAlex count · 12,732 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 977 | 473 | 217 |
| 2025 | 1,163 | 502 | 1,705 |
| 2024 | 840 | 403 | 3,948 |
| 2023 | 716 | 375 | 6,279 |
| 2022 | 823 | 434 | 10,433 |
| 2021 | 804 | 376 | 13,615 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
176 daysMedian, submission to acceptance · P25–P75 129 days – 229 days
- Acceptance to online
- median 9 days (195 articles)
- Submission to online
- median 188 days
- Sample
- 195 articles with submission and acceptance dates (2,331 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 41 daysPublisher website ·
- Peer review
- Open peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,690 / EUR 3,690 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
- Integrative OncologyDeadline
- Financial ToxicityDeadline
What to prepare6 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 4,000 words
- Suggested reviewers
- Required, 3
- Cover letter
- Required
- Not considered
- case studies; papers reporting on unmet needs; pilot/feasibility studies; instrument development studies
Article types accepted9, with length limits
- case studyResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- correspondenceResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- letters to the editorResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- literature reviewResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- meta-analysisResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- protocolResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- reviewResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
- review articleResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…main text ≤ 4,000 words
- systematic reviewResearch – body text is limited to 3500 words. There may be 45 references and no more than six figures/tables.Review – generally solicited by the editors but un…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright and license term – CC BY-NC
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution-NonCommercial 4.0 International License Find more about the license agreement Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Supportive Care in Cancer, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Peer Review Taxonomy
Supportive Care in Cancer and Springer Nature are participating in a pilot of STM's Working Group on Peer Review Taxonomy. STM, the International Association of Scientific, Technical and Medical Publishers, has recognized a need to identify and standardize definitions and terminology in peer review practices in order to help align nomenclature as more publishers use open peer review models. A peer…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1993
- ISSN
- 0941-4355
- Electronic ISSN
- 1433-7339
- Society / sponsor
- Multinational Association of Supportive Care in Cancer
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Supportive Care in Cancer
What CAS zone is Supportive Care in Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Supportive Care in Cancer is in Zone 3 of Medicine, and in Zone 2 of the minor category Rehabilitation / Health Care Sciences & Services / Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Supportive Care in Cancer?
The latest impact factor listed by LetPub is 3.4; CiteScore 5.3, h-index 174.
How long does peer review take at Supportive Care in Cancer?
Based on the dates recorded on 195 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 176 days (interquartile range 129–229 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Supportive Care in Cancer?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 4,000 words; Suggested reviewers: Required, 3; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Supportive Care in Cancer based?
Of the 56 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (21), Canada (7) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Supportive Care in Cancer?
According to LetPub and DOAJ records, Supportive Care in Cancer is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is Supportive Care in Cancer open access, and what is the APC?
Supportive Care in Cancer is a hybrid journal. For open-access publication: APC about USD 4,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .